Cart
sales@molnova.com
Secologanoside
CAS No. 59472-23-0
Secologanoside( —— )
Catalog No. M24588 CAS No. 59472-23-0
Secologanoside shows anti-complementary, allelopathic, and anti-elastase activities.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 180 | In Stock |
|
| 5MG | 170 | In Stock |
|
| 10MG | 255 | In Stock |
|
| 25MG | 430 | In Stock |
|
| 50MG | 607 | In Stock |
|
| 100MG | 862 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameSecologanoside
-
NoteResearch use only, not for human use.
-
Brief DescriptionSecologanoside shows anti-complementary, allelopathic, and anti-elastase activities.
-
DescriptionSecologanoside shows anti-complementary, allelopathic, and anti-elastase activities.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorElastase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number59472-23-0
-
Formula Weight390.34
-
Molecular FormulaC16H22O11
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?H2O : 25 mg/mL (64.05 mM)
-
SMILESC=CC(C1CC(O)=O)C(OC(C(C2O)O)OC(CO)C2O)OC=C1C(O)=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Biological activities of triterpenoids from Poraqueiba sericea stems.Nat Prod Res. 2017 Jun;31(11):1333-1338.
molnova catalog
related products
-
37-DIHYDROXYFLAVONE
37-DIHYDROXYFLAVONE is a natural product extracted from the herbs of Atraphaxis pyrifolia
-
Curculigoside B
Curculigoside B shows antioxidative and antiosteoporotic activities, it can decrease area of bone resorption pit, osteoclastic formation and TRAP activity.
-
Atracurium besylate
Atracurium besylate is a non-depolarizing neuromuscular blocking agent with short duration of action. Its lack of significant cardiovascular effects and its lack of dependence on good kidney function for elimination provide clinical advantage over alternate non-depolarizing neuromuscular blocking agents.
